ADAR1 Capital acquires 1,000 InMed common shares worth $1,555
INM•Share purchase disclosure
- InMed Pharmaceuticals disclosed a purchase of 1,000 common shares at $1.56 by 10% owner ADAR1 Capital Management.
- Indirect holdings rose to 801,000 common shares following the buy.
- ADAR1 manager Daniel Schneeberger was listed as a reporting person.
